Table 1.
Profile of Hepatitis C Patients in the Chronic Hepatitis Cohort Study (N=4781)
| Study Variable* | Total Sample (N) Percent/Mean |
(95% CI) |
|---|---|---|
| Male | (2725) 57.0 | (55.6–58.4) |
| Mean Age (in years) | (4781) 56.7 | (56.2–57.2) |
| White Race | (3395) 71.0 | (69.7–72.3) |
| Married | (2407) 50.4 | (48.9–51.8) |
| Collage Graduate | (974) 20.4 | (19.3–21.5) |
| Employed Full/Part-time/Occasionally | (2181) 47.9 | (46.5–49.4) |
| Private Insurance | (2922) 61.1 | (59.7–62.5) |
| History of IDU | (2458) 51.4 | (50.0–52.8) |
| Ever in Drug Abuse Treatment | (1557) 32.6 | (31.3–33.9) |
| Ever in Alcohol Abuse Treatment | (1479) 30.9 | (29.6–32.3) |
| Current Alcohol Abuse/Dependence** | (839) 17.7 | (16.6–18.8) |
| Ever Heavy Alc. Use, 5+ Drinks/Day | (1971) 41.2 | (39.8–42.6) |
| Current Smoker | (1617) 33.9 | (32.5–35.3) |
| Ever Treated for HCV | (2268) 47.4 | (46.0–48.9) |
| Stopped HCV Meds Past 12 Months | (711) 14.9 | (13.9–15.9) |
| Currently on HCV Meds Past 4 Weeks | (227) 4.7 | (4.2–5.4) |
| Liver Transplant | (285) 6.0 | (5.3–6.7) |
| SVR 12 Weeks | (705) 14.8 | (13.8–15.8) |
| HCV Genotype 1*** | (2486) 84.2 | (82.8–85.5) |
| Decompensated or ESLD | (258) 5.4 | (4.8–6.1) |
| High Charlson Disease Score | (694) 14.5 | (13.6–15.5) |
| PHQ-8 Depression Positive | (1409) 29.7 | (28.4–31.0) |
| SF-8 Poor Physical Health | (1088) 24.6 | (23.3–25.9) |
*
IDU = injection drug use; HCV = hepatitis C virus; SVR = sustained virologic response; ESLD = end stage liver disease; PHQ-8 = Patient Health Questionnaire-8; SF-8 = Short From-8.
**
Based on the AUDIT-C Scale.
***
Genotype based on n = 2,938, due to missing data.